Inivata
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis
Total raised
€45M
€45,236,000
Funding rounds
1
Investors
0
distinct backers
Active since
2018-12
latest 2018-12
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood19
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series B | €45M | — | View deal → |